SurModics saw the highest growth of 2.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of SurModics‘s patent filings and grants. Buy the databook here.
SurModics has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 100% grants. The Australia(AU), United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where SurModics is filings its patents. Among the top granted patent authorities, SurModics has 100% of its grants in United States(US).
Becton Dickinson and Co and Toray Industries could be the strongest competitors for SurModics
In terms of grant share, SurModics stands in eighth position among its competitors. Becton Dickinson and Co and Toray Industries secured the top positions according to recent patent publication data.
Patents related to smart materials lead SurModics's portfolio
SurModics has the highest number of patents in smart materials. For smart materials no patents were filed and 100% of patents were granted in Q2 2024.
Cardiovascular devices related patents lead SurModics portfolio followed by general surgery devices
SurModics has highest number of patents in cardiovascular devices followed by general surgery devices.
For comprehensive analysis of SurModics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.